Latest Share Purchase Plan News

FireFly Metals reports exceptional infill drilling results at its Green Bay Copper-Gold Project, confirming strong mineral continuity and setting the stage for a resource upgrade and mining feasibility studies.

Pacific Edge Limited (ASX – PEB) has announced a securities purchase plan (SPP) aiming to raise up to NZD 5 million, contingent on shareholder approval of a prior NZD 16 million placement. The move is designed to bolster working capital amid ongoing growth initiatives.

Dreadnought Resources has fortified its balance sheet with an $8.5 million capital raise and secured a $15 million joint venture with Teck Resources, advancing its Mangaroon gold and critical minerals projects.

Imugene Limited has launched a $37.5 million equity raising through a Placement and Share Purchase Plan, offering new shares and options to fund its pivotal azer-cel clinical program. The raise includes attaching and piggyback options, subject to shareholder approval, aiming to bolster the company’s immuno-oncology pipeline.

Imugene Limited has launched a A$37.5 million capital raising to advance its promising off-the-shelf CAR T therapy, azer-cel, following encouraging Phase 1b data showing a 75% overall response rate in lymphoma patients.

Imugene Limited has completed a $22.5 million institutional placement and launched a $15 million Share Purchase Plan, both featuring attaching options, to fund its azer-cel clinical program through a pivotal trial in 2026.

Hawsons Iron Limited has successfully raised $1.91 million through an oversubscribed Share Purchase Plan and a targeted Placement, positioning the company to fast-track key project studies and environmental assessments.

Warriedar Resources has announced a landmark mineral resource upgrade at its Ricciardo deposit, now home to Australia’s largest open-pit antimony resource, alongside significant gold discoveries and a successful A$21 million capital raise to accelerate exploration.

Hazer Group has successfully raised $10.7 million through a combination of a share placement and a share purchase plan, positioning the company to advance its innovative clean hydrogen and graphite production technology.

IKE GPS Group Limited has opened a A$2.0 million Share Purchase Plan following an A$18 million placement, aiming to accelerate product innovation and strategic expansion.

Prescient Therapeutics has extended its Share Purchase Plan closing date to 22 July 2025, aiming to raise up to A$7 million to advance its targeted cancer therapy PTX-100 through Phase 2 clinical trials.

RBR Group Limited invites eligible shareholders to participate in a Share Purchase Plan aiming to raise up to $650,000 by offering shares at a highly discounted price of $0.001 each. The capital raised will support a joint venture, debt repayment, and working capital needs.